Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker

Abstract

In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeatic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of vital protein transistion, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolic thereof, a calmodulin blocker and a metabolite thereof, and a plumaceutical acceptable diluent or carrier: and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.

1 - 29 . (canceled) 
     
     
         30 . A method for treating a viral infection presenting in a human with one or more symptoms selected from the group comprising fever, chills, muscle aches, nausea, diarrhea, cramps and lower abdominal pain, the method comprising the step of administering to the human a therapeutically effective amount of a composition comprising a calcium channel blocker or a metabolite thereof and pharmaceutically acceptable diluent or carrier. 
     
     
         31 . The method of  claim 30 , wherein said calcium channel blocker comprises verapamil. 
     
     
         32 . The method of  claim 31 , wherein the composition is administered as a tablet with 120 mg of verapamil. 
     
     
         33 . A method for treating a viral infection presenting in a human with symptoms comprising one or more of diarrhea, cramps and lower abdominal pain, the method comprising administering to the human a therapeutically effective amount of a composition comprising a calcium channel blocker or a metabolite thereof and pharmaceutically acceptable diluent or carrier to treat the one or more symptoms of diarrhea, cramps and lower abdominal pain. 
     
     
         34 . The method of  claim 33 , wherein the calcium channel blocker comprises verapamil. 
     
     
         35 . The method of  claim 31 , wherein the composition is administered as a tablet with 120 mg of verapamil.